Results 181 to 190 of about 1,217,330 (315)

In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure

, 2012
Anuradha Guggilam, Kirk R. Hutchinson, T. Aaron West, Amy P. Kelly, Maarten L. Galantowicz, Amy J. Davidoff, Sakthivel Sadayappan, Pamela A. Lucchesi   +7 more
openalex   +2 more sources

Magnetic resonance imaging in the evaluation of congestive cardiac failure [PDF]

, 2012
Prabhakar Rajiah
openalex   +1 more source

NARFL Knockout Triggers Ferroptosis‐Driven Vascular Endothelial Dysfunction

Advanced Science, EarlyView.
NARFL is vital for CIA and oxidative stress resistance. NARFL deletion in HPMEC cells, zebrafish, and mice is lethal and rescued by a Ferroptosis inhibitor. NARFL deficiency disrupted its interaction with CIA proteins, decreased aconitase activity, increased IRP1 activity, induced Fe overload, and led to ferroptosis and oxidative stress, resulting in ...
Hui Hu, Jing Luo, Li Yu, Daoxi Qi, Boyu Li, Yating Chen, Chen Wang, Xiaokang Zhang, Wenzheng Guo, Qiyong Lou, Gang Zhai, Yonglin Ruan, Jianfei Huang, Shengchi Shi, Zhan Yin, Fang Zheng   +15 more
wiley   +1 more source

Cardiac Failure Forecasting Based on Clinical Data Using a Lightweight Machine Learning Metamodel. [PDF]

Diagnostics (Basel), 2023
Mahmud I, Kabir MM, Mridha MF, Alfarhood S, Safran M, Che D.   +5 more
europepmc   +1 more source

Multidisciplinary cardiac program for patients with heart failure

, 2009
Wing-luen Lee
openalex   +1 more source

Mettl3‐Mediated m6A Modification Represents a Novel Therapeutic Target for FSGS

Advanced Science, EarlyView.
This study explores the roles of Mettl3‐induced N6‐methyladenosine (m6A) modifications in Focal segmental glomerulosclerosis (FSGS). The findings reveal that inhibition of Mettl3 results in podocyte injury by modulating the TJP1CDC42 pathway. Moreover, Administration of N6‐methyladenosine attenuates the FSGS phenotype in WT mice induced by Adriamycin ...
Fubin Zhu, Hongzhi Li, Xiang Li, Chunxiu Du, Ting Wang, Xuling Zhou, Xiaobei Xie, Yunxia Shao, Yingzhi Huang, Yanling Hu, Xinxin Guo, Bin Zhu, Shanshan Yu, Xiaoyan Zhang, Binghai Zhao   +14 more
wiley   +1 more source

Efficacy of embolo/sclerotherapy in the treatment of high-output cardiac failure caused by peripheral arteriovenous malformations. [PDF]

Front Cardiovasc Med
Guo X, Nie Q, Zheng K, Ni B, Yang Y, Ye Z, Liu P, Fan X.   +7 more
europepmc   +1 more source

Transbronchial needle aspiration in severe cardiac failure patient: 'The old bull knows best'. [PDF]

Respirol Case Rep, 2023
Caterino U, Cesaro C, Lucci R, Cesaro F, Masi U, Cotroneo A, Amore D.   +6 more
europepmc   +1 more source

Circular RNA PTPN4 Contributes to Blood‐Brain Barrier Disruption during Early Epileptogenesis

Advanced Science, EarlyView.
Epileptic condition induces CircPTPN4 upregulation, which promotes ECE‐1 expression through competitive sequestration of miR‐145a‐5p. The elevated ECE‐1 catalyzes the ET‐1 production, leading to p38/MAPK pathway activation and subsequent downregulation of tight junction protein expression. This cascade results in increased BBB permeability and enhanced
Jiurong Yang, Yang Hu, Feiyu Wang, Xintao Peng, Honggang Qi, Yuanyuan Yao, Canyu Zhang, Lijie Zhou, Xuemei Liang, Kang Xu, Cong Zhang, Aifeng Zhang, Chen Chen, Yu Zeng, Chenchen Zhang, Guangming Gan, Xinjian Zhu   +16 more
wiley   +1 more source

Real-world disproportionality analysis of cardiac failure associated with novel antineoplastic agents in breast cancer: a pharmacovigilance study. [PDF]

Front Immunol
Li H, Wu Y, Guo Q, Guo C, Liu F, Huo L.
europepmc   +1 more source